Table 2.
UK Biobank study |
Meta-analysis of independent studies |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Model | Samples | β | LCI | UCI | P | N | β | LCI | UCI | P | N |
BMI ∼ insulin secretion GRS | All individuals | −0.004 | −0.010 | 0.001 | 0.14 | 119 688 | 0.001 | −0.010 | 0.013 | 0.8 | 30 440 |
Type 2 diabetes controls | −0.010 | −0.016 | −0.005 | 5E-4 | 113 203 | −0.008 | −0.019 | 0.004 | 0.2 | 25 039 | |
Type 2 diabetes cases | −0.036 | −0.065 | −0.007 | 0.015 | 4003 | −0.037 | −0.062 | −0.012 | 0.004 | 5396 | |
All individuals adjusted for type 2 diabetes status | −0.011 | −0.017 | −0.006 | 1E-4 | 117 206 | −0.013 | −0.021 | −0.005 | 0.002 | 30 435 | |
BMI ∼ blood pressure GRS | All individuals | −0.014 | −0.020 | −0.008 | 1E-6 | 119 688 | −0.008 | −0.020 | 0.004 | 0.2 | 25 059 |
Normotensive controls | −0.034 | −0.043 | −0.026 | 2E-16 | 53 377 | −0.014 | −0.028 | 0.000 | 0.06 | 18 590 | |
Hypertensive cases | −0.031 | −0.039 | −0.024 | 4E-16 | 65 584 | −0.042 | −0.063 | −0.021 | 9E-5 | 8267 | |
All individuals adjusted for hypertension status | −0.033 | −0.038 | −0.027 | 7E-31 | 118 961 | −0.022 | −0.034 | −0.010 | 4E-4 | 25 049 |